Private Placement Form 8 K

Item 3.02.Unregistered Sales of Equity Securities.

​

On June 27, 2024, Fortress Biotech, Inc. ("Fortress") issued 2,028,345 shares (the "Shares")of its common stock, par value $0.001 per share ("Common Stock"), to the former holders of the 8% Cumulative Convertible Class B Preferred Stock (the "Urica Preferred Stock") of Urica Therapeutics, Inc., a subsidiary of Fortress ("Urica"). The issuance of the Shares was in satisfaction of obligations under that certain Dividend Payment and Exchange Agreement dated as of December 27, 2022 (the "Dividend Agreement"), between Fortress and Urica for the benefit of the holders of the Urica Preferred Stock. Fortress originally entered into the Dividend Agreement as a partial inducement to investors in the previously disclosed private offering by Urica of the Urica Preferred Stock.

​

Under the Dividend Agreement and the terms of the Urica Preferred Stock, Fortress agreed to (i) pay cumulative dividends on the Urica Preferred Stock in shares of Common Stock and (ii) at its election pay cash or issue new shares of Common Stock to the holders of the Urica Preferred Stock, in exchange for their mandatory tender to Fortress of their shares of Urica Preferred Stock, upon the occurrence of certain dates and conditions set forth in the Certificate of Designations of Rights and Preferences for the Urica Preferred Stock. On June 27, 2024, based on the formula provided by the terms of the Urica Preferred Stock, Fortress elected to issue the Shares, rather than pay cash, and paid $20,747.62 in lieu of fractional shares and for accumulated and unpaid dividends that would otherwise have been payable in Common Stock, upon its receipt of all of the issued and outstanding shares of Urica Preferred Stock from the prior holders of such Urica Preferred Stock. The foregoing issuances were made in a transaction exempt from registration under the Securities Act of 1933, as amended (the "Securities Act"), pursuant to Section 4(a) thereof. The Shares may not be sold or transferred absent registration under the Securities Act or an exemption therefrom. The resale of the Shares by the former holders of the Urica Preferred Stock has been registered under the Securities Act on a registration statement that was declared effective on June 27, 2024.

​

​

​

​

Public link

Please use the above public link if you want to share this noodl on another website.